NeuragenPain Relief (Origin Biomed Inc)


Welcome to the PulseAid listing for the Neuragen drug offered from Origin Biomed Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Origin Biomed Inc
NON-PROPRIETARY NAME: Hypericum, Aconitum Napellus, Lycopodium, Phosphorus, Rhus Toxicodendron
SUBSTANCE NAME: HYPERICUM PERFORATUM; ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-05-01
END MARKETING DATE: 0000-00-00


Neuragen Pain Relief HUMAN OTC DRUG Details:

Item DescriptionNeuragen Pain Relief from Origin Biomed Inc
LABELER NAME: Origin Biomed Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 12; 12; 12; 12; 12([hp_C]/8g; [hp_C]/8g; [hp_C]/8g; [hp_C]/8g; [hp_C]/8g; [hp_C]/8g)
START MARKETING DATE: 2009-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15377-006_10554f30-db0e-4db4-a95a-936c40654e16
PRODUCT NDC: 15377-006
APPLICATION NUMBER:

Other HYPERICUM PERFORATUM; ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; CLAVICEPS PURPUREA SCLEROTIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Origin Biomed IncNeuragen PN